GAITHERSBURG, Md. (AP) – A pharmaceutical company in Maryland will acquire Narcan opioid overdose nasal spray manufacturer.
The Baltimore Sun reports that Emergent Solutions has agreed to pay $ 735 million in cash and shares to Ireland. based Adapt Pharma. CEO Daniel J. Abdun-Nabi said in a Wednesday statement that the widely used drug is consistent with Emergent's position to "protect and improve life".
The federal government has declared the opioid epidemic a public health emergency claiming thousands of lives. 19659002] Narcan is the only approved nasal spray version of Naxolon that costs $ 1
Doug White of Emergent says the company plans to invest in addiction and overdose drugs and work with federal officials to ensure grants to offset costs
This article has been corrected to to correct the spelling of Doug White's first name.
Information from: The Baltimore Sun, http://www.baltimoresun.com
Copyright 2018 The Connected Press. All rights reserved. This material may not be published, transmitted, rewritten or redistributed.